Literature DB >> 12218053

A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression.

Qianben Wang1, Dipali Sharma, Yunsheng Ren, Joseph D Fondell.   

Abstract

The human thyroid hormone receptor-associated protein (TRAP)-Mediator complex was originally identified as a large multimeric complex that copurifies with the thyroid hormone receptor (TR) from HeLa cells and markedly enhances TR-mediated transcription in vitro. More recent studies have implicated TRAP-Mediator as a coactivator for a broad range of nuclear hormone receptors as well as other classes of transcriptional activators. Here we present evidence that TRAP-Mediator plays a functional role in androgen receptor (AR)-mediated transcription. We show that several subunits of the complex ligand-dependently coimmunoprecipitate with AR from both prostate cancer LNCaP cells and from HeLa cells stably transfected with AR. The 220-kDa subunit of the complex (TRAP220) can contact the ligand-binding domain of AR in vitro, possibly implicating TRAP220 involvement in targeting AR to the holocomplex. Consistent with a TRAP-Mediator coactivator role, transient overexpression of the TRAP220, TRAP170, and TRAP100 subunits enhanced ligand-dependent transcription by AR in cultured cells. Finally, chromatin immunoprecipitation assays show that TRAP220 is recruited to the androgen-responsive prostate-specific antigen gene promoter in vivo in ligand-stimulated LNCaP cells. Collectively, these data suggest that TRAP-Mediator may play an important coregulatory role in AR-mediated gene expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218053     DOI: 10.1074/jbc.M206061200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence.

Authors:  Tihana Ibrahimpasic; Bin Xu; Iñigo Landa; Snjezana Dogan; Sumit Middha; Venkatraman Seshan; Shyam Deraje; Diane L Carlson; Jocelyn Migliacci; Jeffrey A Knauf; Brian Untch; Michael F Berger; Luc Morris; R Michael Tuttle; Timothy Chan; James A Fagin; Ronald Ghossein; Ian Ganly
Journal:  Clin Cancer Res       Date:  2017-06-20       Impact factor: 12.531

2.  A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth.

Authors:  Qianben Wang; Wei Li; X Shirley Liu; Jason S Carroll; Olli A Jänne; Erika Krasnickas Keeton; Arul M Chinnaiyan; Kenneth J Pienta; Myles Brown
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

Review 3.  The mediator of RNA polymerase II.

Authors:  Erik Blazek; Gerhard Mittler; Michael Meisterernst
Journal:  Chromosoma       Date:  2005-02-03       Impact factor: 4.316

4.  MED1 phosphorylation promotes its association with mediator: implications for nuclear receptor signaling.

Authors:  Madesh Belakavadi; Pradeep K Pandey; Ravi Vijayvargia; Joseph D Fondell
Journal:  Mol Cell Biol       Date:  2008-04-07       Impact factor: 4.272

Review 5.  Androgen receptor-driven chromatin looping in prostate cancer.

Authors:  Dayong Wu; Chunpeng Zhang; Yanping Shen; Kenneth P Nephew; Qianben Wang
Journal:  Trends Endocrinol Metab       Date:  2011-08-31       Impact factor: 12.015

6.  Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth.

Authors:  Zhong Chen; Chunpeng Zhang; Dayong Wu; Hongyan Chen; Anna Rorick; Xiaoting Zhang; Qianben Wang
Journal:  EMBO J       Date:  2011-05-10       Impact factor: 11.598

7.  Purification and identification of a novel complex which is involved in androgen receptor-dependent transcription.

Authors:  Keiko Hosohata; Peng Li; Yoshiaki Hosohata; Jun Qin; Robert G Roeder; Zhengxin Wang
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  ERK and AKT signaling drive MED1 overexpression in prostate cancer in association with elevated proliferation and tumorigenicity.

Authors:  Feng Jin; Shazia Irshad; Wei Yu; Madesh Belakavadi; Marina Chekmareva; Michael M Ittmann; Cory Abate-Shen; Joseph D Fondell
Journal:  Mol Cancer Res       Date:  2013-03-28       Impact factor: 5.852

9.  Nicotinamide uncouples hormone-dependent chromatin remodeling from transcription complex assembly.

Authors:  Sayura Aoyagi; Trevor K Archer
Journal:  Mol Cell Biol       Date:  2007-10-22       Impact factor: 4.272

10.  A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression.

Authors:  Feng Jin; Joseph D Fondell
Journal:  Nucleic Acids Res       Date:  2009-06-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.